Home
Conditions
Advanced Cancers

Clinical trial condition

Advanced Cancers

Explore clinical trials studying Advanced Cancers. Study availability and eligibility vary by location and protocol.

60 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Advanced Cancers trial results

Completed

Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor

NCT01277744

Conditions: Advanced Cancers, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, +18 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion

NCT02498899

Conditions: Advanced Cancers
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab

NCT01213238

Conditions: Advanced Cancers
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Ipilimumab and Lenalidomide in Advanced Cancer

NCT01750983

Conditions: Advanced Cancers, Neoplasms
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers

NCT01563302

Conditions: Advanced Cancers, DLBCL, Hemic and Lymphatic Diseases, +7 more
Locations: Mayo Clinic Arizona Scottsdale, Arizona, United States

Moores UC San Diego Cancer Center La Jolla, California, United States

Yale Cancer Center New Haven, Connecticut, United States

Blood and Marrow Transplant Group of Georgia at Northside Hospital Atlanta, Georgia, United States

View Trial Details

Completed

Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention

NCT02422329

Conditions: Advanced Cancers, Constipation, Disease Attributes, +8 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)

NCT01653717

Conditions: Advanced Cancers, Chronic Disease, Disease Attributes, +14 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Erlotinib in Combination With Pralatrexate in Advanced Malignancies

NCT01532011

Conditions: Advanced Cancers, Solid Tumors
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

NCT01183663

Conditions: Adenocarcinoma, Advanced Cancers, Astrocytoma, +68 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors

NCT01454804

Conditions: Advanced Cancers
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Advanced Cancers

Advanced Cancers trial results

Related conditions